MiNK Therapeutics, Inc.INKTNASDAQ
Loading
Total Assets Over TimeContracting
Percentile Rank60
3Y CAGR-47.8%
5Y CAGR+34.3%
Studio
Year-over-Year Change

Total value of everything the company owns

3Y CAGR
-47.8%/yr
Annual compound
5Y CAGR
+34.3%/yr
Recent deceleration
Percentile
P60
Within normal range
vs 5Y Ago
4.4x
Strong expansion
Streak
1 yr
Consecutive growthContracting
PeriodValueYoY Change
2024$5.72M+25.7%
2023$4.55M-78.8%
2022$21.47M-46.6%
2021$40.24M+783.4%
2020$4.56M+248.0%
2019$1.31M-